Trial Profile
A single arm, multicentric, open label, efficacy and safety study of Docetaxel Lipid Suspension for Injection of Intas Pharmaceuticals Limited, India in patients with Metastatic Castration Resistant prostate cancer
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Intas Pharmaceuticals
- 25 Jun 2018 New trial record